Indian stocks: Visit www.stage2stocks.com →

LifeStance Health Group, Inc.

Stage 2 · Advancing · week 24

As of Oct 22, 2026, LifeStance Health Group is in Stage 2, the uptrend phase, now in week 24 (since May 7, 2026). It closed at $12.56, 6.1% below its 52-week high and above its 200-day average, which is rising.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. More about the company

$12.56
+1.87% today
$4.8B · Mid cap
Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 17 in Medical Care Facilities · #1 of 272 in Health Care

Is LFST early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 26w
S2 24w
S4 19w
S2 14w
S2 24w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 7w → S4 9w → S1 9w → S4 26w → S1 5w → S2 24w → S3 5w → S4 19w → S1 13w → S2 14w → S3 7w → S2 24w current
Total tracked: 165 weeks across 13 stage runs.

LFST among Medical Care Facilities3rd of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
vs 52W High
-6.1%
$4.81 lo$13.38 hi
6.1% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 24
1w13w26w
Week 24, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
37.1%
200 DMA: $9.16 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.96x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+4.0%
3M
+15.2%
6M
+79.7%
YTD
+80.5%
1Y
+141.5%
Scan Membership
Breakout Watch
Latest: 2024-10-07
2 appearances in last 60 days. First seen: 2023-04-21.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 24 · Vol 0.96x
2026-10-21S2
Wk 24 · Vol 0.74x
2026-10-20S2
Wk 23 · Vol 0.43x
2026-10-19S2
Wk 23 · Vol 0.80x
2026-10-16S2
Wk 23 · Vol 0.60x
2026-10-15S2
Wk 23 · Vol 0.75x
2026-10-14S2
Wk 23 · Vol 0.73x
2026-10-13S2
Wk 22 · Vol 0.39x
2026-10-12S2
Wk 22 · Vol 0.46x
2026-10-09S2
Wk 22 · Vol 0.38x
2026-10-08S2
Wk 22 · Vol 0.49x
2026-10-07S2
Wk 22 · Vol 0.77x
Moving averages & range
50 DMA
$12.39
200 DMA
$9.16
52W High
$13.38
52W Low
$4.81
5D Low
$11.74
Resistance levels (recent highs)
20d High
$12.56
60d High
$13.38
120d High
$13.38
250d High
$13.38
Next resistance
+6.5%
to 60d High
P/E (TTM)
96.6
Forward 29.2
ROE
+3.4%
Profit margin +3.2%
Dividend Yield
0.00%
P/B 3.2

LifeStance Health Group: quick answers

What stage is LifeStance Health Group in?

As of Oct 22, 2026, LifeStance Health Group (LFST) is in Stage 2, the uptrend phase. It entered Stage 2 on May 7, 2026 and is in week 24. What the four stages mean

Is LifeStance Health Group in an uptrend?

Yes. LifeStance Health Group is in a Stage 2 uptrend. It trades 37.1% above its 200-day average, which is rising.

How far is LifeStance Health Group from its 52-week high?

LifeStance Health Group closed at $12.56 on Oct 22, 2026, 6.1% below its 52-week high of $13.38. Its 52-week low is $4.81.

How has LifeStance Health Group performed over the past year?

As of Oct 22, 2026, LifeStance Health Group is up 141.5% over the past year and up 80.5% so far in 2026.

Which sector and industry is LifeStance Health Group in?

LifeStance Health Group is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.